Hypnosedative prescribing in outpatient psychiatry.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 8609061 Publication Model: Print Cited Medium: Internet ISSN: 1473-5857 (Electronic) Linking ISSN: 02681315 NLM ISO Abbreviation: Int Clin Psychopharmacol Subsets: MEDLINE
    • Publication Information:
      Publication: London : Lippincott Williams And Wilkins
      Original Publication: London : Clinical Neuroscience Publishers, c1986-
    • Subject Terms:
      Practice Patterns, Physicians'*; Antipsychotic Agents/*therapeutic use ; Hypnotics and Sedatives/*therapeutic use ; Mental Disorders/*drug therapy; Adult ; Ambulatory Care Facilities ; Community Mental Health Services ; Diagnostic and Statistical Manual of Mental Disorders ; Drug Prescriptions ; Drug Therapy, Combination ; Female ; Humans ; Male ; Medical Records ; Middle Aged ; Mood Disorders/drug therapy ; New Zealand ; Retrospective Studies ; Schizophrenia/drug therapy ; Sex Characteristics
    • Abstract:
      The objective of this study was to describe hypnosedative (HS) prescribing patterns in a typical sample of psychiatric outpatients. Prescription information was extracted from the clinical records of all current outpatients at two New Zealand public mental health centres. This included the type and duration of HS use and documentation of a clinical review of longstanding (>3 months) use, patient sex, age and ICD10 diagnoses. One-third of the patients (35.2%) were prescribed at least one HS; this was longstanding in two-thirds (69%). One in 10 had a coprescription of more than one HS drug. HS use was related to female sex and diagnosis, being more common among patients with nonpsychotic than psychotic disorders and very infrequent in patients on clozapine. In most longstanding cases, a clinical review had been documented. The logistic regression confirmed female sex, diagnosis and clozapine all as independent predictors of HS prescription. HS prescribing in psychiatric illness is more common than in the general population, often longstanding, with polypharmacy being common. The frequent use of antipsychotic drugs as HSs is of concern, given their side-effect profile. As there are risks involved with longstanding HS use, a better rationale for the role of medication in the management of sleep problems in psychiatric disorders is needed.
    • Accession Number:
      0 (Antipsychotic Agents)
      0 (Hypnotics and Sedatives)
    • Publication Date:
      Date Created: 20130518 Date Completed: 20140117 Latest Revision: 20151119
    • Publication Date:
      20231215
    • Accession Number:
      10.1097/YIC.0b013e32836248f1
    • Accession Number:
      23680995